Indications and uses
Temporary relief of minor pain associated with: • arthritis • strains • bruises • sprains • injuries • sore muscles and joints As per Homeopathic Materia Medica.
Temporary relief of minor pain associated with: • arthritis • strains • bruises • sprains • injuries • sore muscles and joints As per Homeopathic Materia Medica.
adults and children 2 years of age and older apply liberally to the affected area, rubbing gently until fully absorbed use once every half hour within the first four hours of pain, then 3 times daily children under 2 years of age: consult a physician
store below 30°C protect from strong magnetic fields tamper resistant: do not use if inner protective seal is broken
Arnica 30C, 6X HPUS, Belladonna 30C,6X HPUS, Bellis 30C, 6X HPUS, Bryonia 12C, 6X HPUS, Cuprum Acet 12X HPUS,Cuprum Sulph 12X HPUS, Calendula 12C, 6X HPUS, Hypericum 30C, 6X HPUS, Ledum 12C HPUS, Rhus Tox 30C, 6X HPUS, Ruta 30C, 6X HPUS, Symphytum 12X HPUS, Sulphuricum Ac 6X HPUS, Calc Fluor 12C,10X HPUS, Calc Phos 10X HPUS, Calc Sulph 6X HPUS, Ferrum Phos 12C, 10X HPUS, Kali Mur 6X HPUS, Kali Phos 6X HPUS, Kali Sulph 6X HPUS, Mag Phos 30C, 10X HPUS, Nat Mur 12X HPUS, Nat Phos 6X HPUS, Nat Sulphuricum 12C, 6X HPUS.
The letters “HPUS” indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States
Minor Pain Reliever
| Temporary relief of minor pain associated with: • arthritis • strains • bruises • sprains • injuries • sore muscles and joints As per Homeopathic Materia Medica. |
FOR EXTERNAL USE ONLY.
If pregnant or breast feeding,ask a health professional before use.
Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center right away.
Aloe Barbadensis Leaf Juice, Carbomer, Citrus Lemon (Lemon) Fruit Water, Glycerin, Lonicera japonica (Honeysuckle) Flower Extract, Lonifera Caprifolum (Honeysuckle) Extract, Purified Water
1-877-Bionica (1-877-246-6422)
| Distributed by: Origin BioMed Inc. 102 Chain Lake Dr, Unit 1K, Halifax, N.S, Canada, B3S 1A7 MADE IN U.S.A. |
NDC: 15377-012-03
PAIN RELIEVING
TEMPORARILY RELIEVES MINOR PAIN ASSOCIATED WITH:
ARTHRITIS, STRAINS, BRUISES, SPRAINS, INJURIES, SORE MUSCLES AND JOINTS
• NON-GREASY
• NO CAPSAICIN
• NO MENTHOL
24 Active Ingredients: including Arnica, Magnesium, Potassium and Calcium
HOMEOPATHIC
NET WT 3 oz (85 g)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 15377-012-03 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-403b-60a7-e053-dbdaa90a05bd | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 15377-012-03 | Bionica Pain Relieving Gel | 1 in 1 CARTON | GEL | 1 | 4 | |
| 15377-012-03 | Bionica Pain Relieving Gel | 85 g in 1 TUBE | GEL | 85 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 15377-012 | BIONICA PAIN RELIEVING GEL (ARNICA, BELLADONNA, BELLIS, BRYONIA, CUPRUM ACET, CUPRUM SULPH, CALENDULA, HYPERICUM, LEDUM, RHUS TOX, RUTA, SYMPHYTUM, SULPHURICUM AC, CALC FLUOR, CALC PHOS, CALCH SULPH, FERRUM PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPHURICUM) GEL [ORIGIN BIOMED INC.] | 4 | Legacy NDC, 2 package rows | 20140528_42baa51d-7116-4cc7-a839-26bcec7640ba.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARNICA MONTANA FLOWER | ACTIVE INGREDIENT | OZ0E5Y15PZ | 4 | |
| ATROPA BELLADONNA | ACTIVE INGREDIENT | WQZ3G9PF0H | 4 | |
| BELLIS PERENNIS | ACTIVE INGREDIENT | 2HU33I03UY | 4 | |
| BRYONIA ALBA ROOT | ACTIVE INGREDIENT | T7J046YI2B | 4 | |
| CALCIUM FLUORIDE | ACTIVE INGREDIENT | O3B55K4YKI | 4 | |
| CALCIUM SULFATE ANHYDROUS | ACTIVE INGREDIENT | E934B3V59H | 4 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE INGREDIENT | 18E7415PXQ | 4 | |
| COMFREY ROOT | ACTIVE INGREDIENT | M9VVZ08EKQ | 4 | |
| CUPRIC ACETATE | ACTIVE INGREDIENT | 39M11XPH03 | 4 | |
| CUPRIC SULFATE | ACTIVE INGREDIENT | LRX7AJ16DT | 4 | |
| FERROSOFERRIC PHOSPHATE | ACTIVE INGREDIENT | 91GQH8I5F7 | 4 | |
| HYPERICUM PERFORATUM | ACTIVE INGREDIENT | XK4IUX8MNB | 4 | |
| LEDUM PALUSTRE TWIG | ACTIVE INGREDIENT | 877L01IZ0P | 4 | |
| MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | ACTIVE INGREDIENT | HF539G9L3Q | 4 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 4 | |
| POTASSIUM PHOSPHATE, DIBASIC | ACTIVE INGREDIENT | CI71S98N1Z | 4 | |
| POTASSIUM SULFATE | ACTIVE INGREDIENT | 1K573LC5TV | 4 | |
| RUTA GRAVEOLENS FLOWERING TOP | ACTIVE INGREDIENT | N94C2U587S | 4 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 4 | |
| SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | ACTIVE INGREDIENT | 70WT22SF4B | 4 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 4 | |
| SULFURIC ACID | ACTIVE INGREDIENT | O40UQP6WCF | 4 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 4 | |
| TRIBASIC CALCIUM PHOSPHATE | ACTIVE INGREDIENT | 91D9GV0Z28 | 4 | |
| ARNICA MONTANA FLOWER | ACTIVE MOIETY | OZ0E5Y15PZ | 4 | |
| ATROPA BELLADONNA | ACTIVE MOIETY | WQZ3G9PF0H | 4 | |
| BELLIS PERENNIS | ACTIVE MOIETY | 2HU33I03UY | 4 | |
| BRYONIA ALBA ROOT | ACTIVE MOIETY | T7J046YI2B | 4 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 4 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE MOIETY | 18E7415PXQ | 4 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 4 | |
| COMFREY ROOT | ACTIVE MOIETY | M9VVZ08EKQ | 4 | |
| CUPRIC CATION | ACTIVE MOIETY | 8CBV67279L | 4 | |
| FERROSOFERRIC PHOSPHATE | ACTIVE MOIETY | 91GQH8I5F7 | 4 | |
| FLUORIDE ION | ACTIVE MOIETY | Q80VPU408O | 4 | |
| HYPERICUM PERFORATUM | ACTIVE MOIETY | XK4IUX8MNB | 4 | |
| LEDUM PALUSTRE TWIG | ACTIVE MOIETY | 877L01IZ0P | 4 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 4 | |
| PHOSPHATE ION | ACTIVE MOIETY | NK08V8K8HR | 4 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 4 | |
| RUTA GRAVEOLENS FLOWERING TOP | ACTIVE MOIETY | N94C2U587S | 4 | |
| SODIUM SULFATE ANHYDROUS | ACTIVE MOIETY | 36KCS0R750 | 4 | |
| SULFATE ION | ACTIVE MOIETY | 7IS9N8KPMG | 4 | |
| SULFURIC ACID | ACTIVE MOIETY | O40UQP6WCF | 4 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 4 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 4 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 4 | |
| LONICERA CAPRIFOLIUM FLOWER | INACTIVE INGREDIENT | 5N1WD9784U | 4 | |
| LONICERA JAPONICA FLOWER | INACTIVE INGREDIENT | 4465L2WS4Y | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 15377-012 | 15377-012-03 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| db8c3872-fe84-46af-b155-9952d9154926 | 42baa51d-7116-4cc7-a839-26bcec7640ba | 2014-05-23 | Warnings | db8c3872-fe84-46af-b155-9952d9154926 42baa51d-7116-4cc7-a839-26bcec7640ba |
Adverse event summaries are temporarily unavailable. Other product information remains available.